Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

Clinical trial NCT01647516 · COMPLETED

Trial details

NCT number: NCT01647516
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2012-12-26
Primary completion: 2015-03-10
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.